<p>A breakthrough study led by <a href="https://www.texasheart.org/people/mehdi-razavi/">Dr. Mehdi Razavi</a> at <a href="https://www.texasheart.org">The Texas Heart Institute</a> (THI), in collaboration with a biomedical engineering team of <a href="https://www.utexas.edu/" target="_blank">The University of Texas at Austin</a> (UT Austin) Cockrell School of Engineering led by <a href="https://www.bme.utexas.edu/people/faculty-directory/cosgriff-hernandez" target="_blank">Dr. Elizabeth Cosgriff-Hernandez</a>, sets the foundation of a ground-breaking treatment regimen for treating ventricular <a href="https://www.texasheart.org/heart-health/heart-information-center/topics/arrhythmia/">arrhythmia</a>. Their study published in <a href="https://www.nature.com/articles/s41467-023-44419-0.epdf?sharing_token=YZDv4mluW1PVVnl4P47VZNRgN0jAjWel9jnR3ZoTv0NMqz7j1AICFJImSGF2Mt2KoKlQND-NHBWU0L4_tskl8oqdiv0Bw4DRTa8kWQBO1sF4fcQ8mxZb7N2PXcJJQSBCUom0p_xhW2NkCW_xMOQZh1ryABpXRU6Qv01vkIyJ-6g%3D" target="_blank"><em>Nature Communications</em> </a>demonstrates the design and feasibility of a new hydrogel-based pacing modality.The scientific advance is significant considering pain management is highly relevant to overall wellness for patients with heart, lung, and blood diseases. Such innovation in painless defibrillation and preventing arrhythmia could revolutionize cardiac rhythm management.</p>